People who receive the shingles vaccine have a 23% lower risk of cardiovascular events, such as stroke, and coronary heart ...

The Illinois chapter of the Huntington’s Disease Society of America will host a fundraising walk at 10:30 a.m. Sunday, May 18 ...

Depressive symptoms rose progressively in the 15 years leading up to dementia diagnosis, with the highest elevations ...

Prilenia, Ferrer entered collaboration agreement for commercialization and co-development of pridopidine in Europe and other ...

pridopidine failed to meet its primary endpoint of slowing functional decline in adults with HD compared to placebo over 65 weeks of follow-up, measured using the Unified Huntington Disease Rating ...

PTC Therapeutics, Inc. today announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients. The study met its primary endpoint of ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

PTC Therapeutics, Inc.’s PTCT share price has dipped by 21.98%, which has investors questioning if this is right time to buy.

Neurocrine Biosciences, Inc.  today announced the launch of ConnectING with Carnietm, a multimedia awareness campaign in partnership with Grammy-nominated singer-songwriter and mental health advocate, ...

Q1 2025 Earnings Call Transcript May 6, 2025 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $10.04, ...

Bowtie’s new plan is a term-based product with no savings component. Hong Kong-based virtual insurer, Bowtie, launched the ...